Want to see JP:2269 full AI Analyst Report?
2269 Stock Chart & Stats
¥3743.00
¥44.00(1.16%)
At close: 4:00 PM EDT
¥3743.00
¥44.00(1.16%)
Day’s Range― - ―
52-Week Range¥2,907.00 - ¥4,371.00
Previous CloseN/A
Volume344.90K
Average Volume (3M)2.77M
Market Cap
¥1.20T
Enterprise Value¥1.12M
Total Cash (Recent Filing)¥86.35B
Total Debt (Recent Filing)¥138.26B
Price to Earnings (P/E)29.3
Beta0.10
Next Earnings
Nov 10, 2026EPS Estimate
55.43Next Dividend Ex-DateN/A
Dividend Yield2.41%
Share Statistics
EPS (TTM)148.48
Shares Outstanding282,200,000
10 Day Avg. Volume1,647,740
30 Day Avg. Volume2,774,413
Financial Highlights & Ratios
PEG Ratio-0.98
Price to Book (P/B)1.35
Price to Sales (P/S)0.89
P/FCF Ratio-22.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)234.28
Revenue Forecast (FY)¥1.22T
Bulls Say, Bears Say
Bulls Say
Revenue ResilienceTop-line growth indicates continued demand across Meiji’s food, nutrition, and pharmaceutical businesses. Sustained revenue expansion can support scale, distribution strength, and reinvestment, even though profitability remains under pressure.
Conservative LeverageLow leverage and a growing equity base provide financial resilience for a defensive consumer and healthcare group. This balance-sheet strength can preserve flexibility for investment, product development, and navigating cost volatility.
Diversified Operating ModelExposure to both recurring food and nutrition demand and pharmaceutical sales diversifies the earnings base. Multiple product categories and channels can reduce dependence on one market and support resilience across business cycles.
Bears Say
Negative Free Cash FlowNegative free cash flow means current operations are not translating into sufficient cash after investment needs. If sustained, weaker cash conversion could constrain shareholder returns, debt capacity, and funding for long-term growth.
Margin CompressionThe persistent decline in net and EBIT margins suggests weaker earnings quality and reduced operating buffer. Lower profitability makes the business more sensitive to raw-material, manufacturing, pricing, and competitive pressures.
Lower Capital ReturnsFalling return on equity indicates that the enlarged equity base is generating less profit than in prior years. Unless profitability improves, weaker capital efficiency may limit sustainable earnings growth and reduce the effectiveness of reinvestment.
Meiji Holdings Co News
2269 FAQ
What was Meiji Holdings Co Ltd’s price range in the past 12 months?
Meiji Holdings Co Ltd lowest stock price was ¥2907.00 and its highest was ¥4371.00 in the past 12 months.
What is Meiji Holdings Co Ltd’s market cap?
Meiji Holdings Co Ltd’s market cap is ¥1.20T.
When is Meiji Holdings Co Ltd’s upcoming earnings report date?
Meiji Holdings Co Ltd’s upcoming earnings report date is Nov 10, 2026 which is in 78 days.
How were Meiji Holdings Co Ltd’s earnings last quarter?
Meiji Holdings Co Ltd released its earnings results on Aug 05, 2026. The company reported ¥56.33 earnings per share for the quarter, beating the consensus estimate of ¥52.375 by ¥3.955.
Is Meiji Holdings Co Ltd overvalued?
According to Wall Street analysts Meiji Holdings Co Ltd’s price is currently Overvalued.
Does Meiji Holdings Co Ltd pay dividends?
Meiji Holdings Co Ltd pays a Semiannually dividend of ¥55 which represents an annual dividend yield of 2.41%. See more information on Meiji Holdings Co Ltd dividends here
What is Meiji Holdings Co Ltd’s EPS estimate?
Meiji Holdings Co Ltd’s EPS estimate is 55.43.
How many shares outstanding does Meiji Holdings Co Ltd have?
Meiji Holdings Co Ltd has 282,200,000 shares outstanding.
What happened to Meiji Holdings Co Ltd’s price movement after its last earnings report?
Meiji Holdings Co Ltd reported an EPS of ¥56.33 in its last earnings report, beating expectations of ¥52.375. Following the earnings report the stock price went down -1.123%.
Which hedge fund is a major shareholder of Meiji Holdings Co Ltd?
Currently, no hedge funds are holding shares in JP:2269
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Meiji Holdings Co Ltd
Meiji Holdings Co., Ltd., established in Tokyo, Japan, in 1916, operates globally as a prominent manufacturer and seller across two core business segments: Food and Pharmaceutical. Its extensive Food division produces and markets a wide array of products, including various dairy items like yogurts, milk, cheeses, butter, and ice cream. This segment also encompasses a diverse selection of confectioneries, such as chocolates, gummy treats, and candies, alongside nutritional offerings like sports supplements, infant formulas, and beauty aids. Further contributions from the Food sector include frozen foods, sugar, over-the-counter medications, and livestock products, complemented by essential transportation and distribution services. The Pharmaceutical segment is dedicated to the development and provision of human health solutions, specifically targeting infectious diseases and central nervous system disorders, as well as manufacturing generic drugs, human and animal vaccines, and blood plasma products. Additionally, this division supplies a comprehensive range of veterinary medicines for livestock, fisheries, and companion animals, covering antimicrobials, pain relief, anti-inflammatory agents, and specialized treatments, alongside agricultural and livestock chemicals.
Technical Analysis
Ajinomoto Co
―
Kewpie Corporation
―
Ezaki Glico Co., Ltd.
―
Morinaga Milk Industry Co., Ltd.
―
MEGMILK SNOW BRAND Co., Ltd.
―